← Leaderboards
Bruce T Lamb
Case Western Reserve University
$28,978,707
Attributed
$57,766,730
Total exposure
22
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $29.5M · FY2005–25$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$181,765,870 · 25
By mechanism
U54$132,064,483 · 8
R01$18,005,589 · 7
U01$13,714,901 · 2
RF1$13,271,333 · 4
T32$2,338,602 · 1
R56$1,329,167 · 1
Top collaborators
- Paul Richard Territo28 shared
- Gregory W Carter27 shared
- Gareth R Howell27 shared
- Gary E. Landreth10 shared
- Alan D. Palkowitz10 shared
- Adrian Lynn Oblak8 shared
- Richard M Ransohoff7 shared
- Stephen Mark Rao7 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Stephen Matthew Carpenter$1,808,105
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseMouse ModelS Disease ModelUniversitiesIndianaNerve DegenerationCause Of DeathInsightCommunitiesUnited StatesAnimal ModelDisabilityElderlyDementiaGenesGenerationsLaboratoriesFundingPhenotypeUnited States National Institutes Of HealthGeneticVariantResources
Grant awards (102)
IU/JAX/PITT MODEL-AD Center$9,833,325
U54 · FY2025 · AG · contact PI
IUSM TREAT-AD Center$8,323,362
U54 · FY2025 · AG
Microphysiological systems to Advance Precision medicine for Alzheimer's Disease and Related Dementias (MAP-AD)$3,335,016
U54 · FY2025 · AG
Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease$2,815,466
U01 · FY2025 · AG
Optimization of SHIP1 Inhibitors for the Treatment of Alzheimer's Disease$2,217,438
U01 · FY2025 · AG
Full human gene replacement mouse models of Alzheimer's Disease$1,321,156
R01 · FY2025 · AG
Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis$730,718
R01 · FY2025 · AG · contact PI
Administrative and Coordination Core$608,890
U54 · FY2025 · AG · contact PI
Training Grant on Alzheimer's Disease and ADRD at Indiana University$279,485
T32 · FY2025 · AG
IU/JAX/PITT MODEL-AD Center$9,833,325
U54 · FY2024 · AG · contact PI
Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease$2,918,576
U01 · FY2024 · AG
Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis$753,556
R01 · FY2024 · AG · contact PI
Deciphering the role of CX3CR1 in Modulating Mechanisms of Amyloid driven Neurodegeneration in Alzheimer's Disease$746,243
R01 · FY2024 · AG · contact PI
Administrative and Coordination Core$608,889
U54 · FY2024 · AG · contact PI
Training Grant on Alzheimer's Disease and ADRD at Indiana University$546,393
T32 · FY2024 · AG
Administrative and Coordination Core$397,063
U54 · FY2024 · AG · contact PI
IU/JAX/PITT MODEL-AD Center: Prophylactic Treatment of Long acting GM-CSF (BBT-007) in B6.hAβsaa mice$397,063
U54 · FY2024 · AG · contact PI
IU/JAX/PITT MODEL-AD Center$9,833,325
U54 · FY2023 · AG · contact PI
IUSM Alzheimer's Disease Drug Discovery Center$7,297,939
U54 · FY2023 · AG
Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease$2,888,439
U01 · FY2023 · AG
Administrative and Coordination Core$604,772
U54 · FY2023 · AG · contact PI
Training Grant on Alzheimer's Disease and ADRD at Indiana University$512,594
T32 · FY2023 · AG
IU/JAX/PITT MODEL-AD Center: Toxicant Exposure Supplement$442,125
U54 · FY2023 · AG · contact PI
IUSM Alzheimer's Disease Drug Discovery Center$351,158
U54 · FY2023 · AG
IU/JAX/PITT MODEL-AD Center$9,790,785
U54 · FY2022 · AG · contact PI
IUSM Alzheimer's Disease Drug Discovery Center$7,389,487
U54 · FY2022 · AG
Full human gene replacement mouse models of Alzheimer's Disease$4,147,326
RF1 · FY2022 · AG
Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease$2,874,982
U01 · FY2022 · AG
Administrative and Coordination Core$634,022
U54 · FY2022 · AG · contact PI
Training Grant on Alzheimer's Disease and ADRD at Indiana University$494,484
T32 · FY2022 · AG
Deciphering the role of CX3CR1 in Modulating Mechanisms of Amyloid driven Neurodegeneration in Alzheimer's Disease (Diversity Supplement)$136,078
RF1 · FY2022 · AG · contact PI
IUSM Alzheimer's Disease Drug Discovery Center$7,452,927
U54 · FY2021 · AG
The IU/JAX Alzheimer's Disease Precision Models Center$5,000,000
U54 · FY2021 · AG · contact PI
Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis$2,333,674
RF1 · FY2021 · AG · contact PI
Project-002$1,848,922
U54 · FY2021 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$1,533,181
R01 · FY2021 · AG
Matched sets of full human gene-replacement mouse lines for MODEL-AD$1,329,167
R56 · FY2021 · AG
Core-003$1,136,511
U54 · FY2021 · AG · contact PI
Training Grant on Alzheimer's Disease and ADRD at Indiana University$505,646
T32 · FY2021 · AG
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$410,013
R01 · FY2021 · AG
IUSM Alzheimer's Disease Drug Discovery Center: PTC Software$393,714
U54 · FY2021 · AG
Administrative and Coordination Core$358,446
U54 · FY2021 · AG · contact PI
IUSM Alzheimer's Disease Drug Discovery Center$7,457,353
U54 · FY2020 · AG
The IU/JAX Alzheimer's Disease Precision Models Center$6,158,485
U54 · FY2020 · AG · contact PI
Deciphering the role of CX3CR1 in Modulating Mechanisms of Amyloid driven Neurodegeneration in Alzheimer's Disease$3,087,997
RF1 · FY2020 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$1,817,926
R01 · FY2020 · AG
Administrative and Coordination Core$435,355
U54 · FY2020 · AG · contact PI
IU/JAX/Pitt MODEL-AD: MAPT-GR$410,930
U54 · FY2020 · AG · contact PI
IU/JAX/Pitt MODEL-AD: Deep Phenotyping Proteomics Year 1$410,578
U54 · FY2020 · AG · contact PI
IU/JAX/Pitt MODEL-AD: Deep Phenotyping Metabolomics Year 1$406,304
U54 · FY2020 · AG · contact PI
IU/JAX/Pitt MODEL-AD: Murinizing Aducanumab$396,250
U54 · FY2020 · AG · contact PI
IU/JAX/PITT MODEL-AD Center: PTC Hardware$389,118
U54 · FY2020 · AG · contact PI
Enzymatic substrates for HTS: IUSM Alzheimer's Disease Drug Discovery Center$243,398
U54 · FY2020 · AG
IUSM Alzheimer's Disease Drug Discovery Center$5,774,436
U54 · FY2019 · AG
The IU/JAX Alzheimer's Disease Precision Models Center$5,000,000
U54 · FY2019 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$2,026,775
R01 · FY2019 · AG
The IU/JAX Alzheimer's Disease Precision Models Center: Aging$475,532
U54 · FY2019 · AG · contact PI
Administrative and Coordination Core$353,486
U54 · FY2019 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: Diet$336,657
U54 · FY2019 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: PTC Transition$283,455
U54 · FY2019 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: Electrophysiology$222,955
U54 · FY2019 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: Microbiome$189,547
U54 · FY2019 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center$5,000,000
U54 · FY2018 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$1,859,251
R01 · FY2018 · AG
Administrative and Coordination Core$353,486
U54 · FY2018 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: Genetic Diversity$344,290
U54 · FY2018 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: Nanostring$229,527
U54 · FY2018 · AG · contact PI
IMMUNE-AD Administrative Supplement To Support a Recruitment Specialist and MRI Pulse Sequence Programming$211,600
R01 · FY2018 · AG
The IU/JAX Alzheimer's Disease Precision Models Center: Drug Selection Criteria$124,395
U54 · FY2018 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center$5,000,000
U54 · FY2017 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$1,682,711
R01 · FY2017 · AG
Administrative and Coordination Core$353,485
U54 · FY2017 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: Metabolomics$176,506
U54 · FY2017 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: Rat F344$155,799
U54 · FY2017 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: PTC Supplement$140,074
U54 · FY2017 · AG · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center$5,000,000
U54 · FY2016 · AG · contact PI
Administrative and Coordination Core$372,016
U54 · FY2016 · AG · contact PI
Central and Peripheral Roles of TREM2 in Alzheimer's Disease$3,528,849
RF1 · FY2015 · AG · contact PI
The role of fractalkine signaling in neurodegenerative disease$343,438
R01 · FY2015 · NS · contact PI
Central and Peripheral Roles of TREM2 in Alzheimer's Disease$37,409
RF1 · FY2015 · AG · contact PI
The role of fractalkine signaling in neurodegenerative disease$340,004
R01 · FY2014 · NS · contact PI
The Role of Monocytes and Microglia in Traumatic Brain Injury-Induced Tauopathies$196,143
R21 · FY2014 · NS · contact PI
The role of fractalkine signaling in neurodegenerative disease$331,418
R01 · FY2013 · NS · contact PI
Modifiers of beta-amyloid metabolism and deposition$289,425
R01 · FY2013 · AG · contact PI
The Role of Monocytes and Microglia in Traumatic Brain Injury-Induced Tauopathies$237,750
R21 · FY2013 · NS · contact PI
The role of fractalkine signaling in neurodegenerative disease$343,438
R01 · FY2012 · NS · contact PI
Modifiers of beta-amyloid metabolism and deposition$306,269
R01 · FY2012 · AG · contact PI
The role of fractalkine signaling in neurodegenerative disease$343,438
R01 · FY2011 · NS · contact PI
Modifiers of beta-amyloid metabolism and deposition$306,269
R01 · FY2011 · AG · contact PI
Modifiers of beta-amyloid metabolism and deposition$318,632
R01 · FY2010 · AG · contact PI
Modifiers of beta-amyloid metabolism and deposition$321,850
R01 · FY2009 · AG · contact PI
Modifiers of Beta-Amyloid Metabolism and Deposition$261,646
R01 · FY2008 · AG · contact PI
Modifiers of Beta-Amyloid Metabolism and Deposition$266,985
R01 · FY2007 · AG · contact PI
Modifiers of Beta-Amyloid Metabolism and Deposition$274,959
R01 · FY2006 · AG · contact PI
Modifiers of Beta-Amyloid Metabolism and Deposition$278,843
R01 · FY2005 · AG
Modifiers of Beta-Amyloid Metabolism and Deposition$278,843
R01 · FY2004 · AG
GENETIC MODIFIERS OF ALZHEIMER'S DISEASE ANIMAL MODELS$202,634
P50 · FY2002 · AG
TRANSGENIC MOUSE MODELS OF ALZHEIMERS DISEASE$80,000
R01 · FY2002 · AG
GENETIC MODIFIERS OF ALZHEIMER'S DISEASE ANIMAL MODELS$202,634
P50 · FY2001 · AG
TRANSGENIC MOUSE MODELS OF ALZHEIMERS DISEASE$115,728
R01 · FY2001 · AG
GENETIC MODIFIERS OF ALZHEIMER'S DISEASE ANIMAL MODELS$202,634
P50 · FY2000 · AG
TRANSGENIC MOUSE MODELS OF ALZHEIMERS DISEASE$111,274
R01 · FY2000 · AG